Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Identification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
General mechanism for modulating immunoglobulin effector function
Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 218
Yu, X., Vasiljević, S., Mitchell, D. A., Crispin, M., & Scanlan, C. N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.006 · Cited by 130
Self-citationNMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic Sialylation
Barb, A. W., Meng, L., Gao, Z., Johnson, R. W., Moremen, K. W., & Prestegard, J. H. (2012) · Biochemistry · doi:10.1021/bi300319q · Cited by 117
Bowden, T. A., Baruah, K., Coles, C. H., Harvey, D. J., Yu, X., Song, B.-D., Stuart, D. I., Aricescu, A. R., Scanlan, C. N., Jones, E. Y., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306068g · Cited by 73
Self-citation
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Exceptions to the general lack of glycans in crystal structures can occur when the glycan is buried and partially immobilized within the folds of the protein, such as in the case of the Immunoglobulin-G (IgG) Fc-region (504) (505) (506) , or tightly packed on the surface, such as in the HIV virion (507) (508) (509) .”
BackgroundEmerging principles for the therapeutic exploitation of glycosylation
Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447
“1016/S0969-2126(99)80095-1; pmid: 10425673 5.”
Self-citationImmunoglobulin G glycosylation in aging and diseases
Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 408
The Structural Role of Antibody N-Glycosylation in Receptor Interactions
Subedi, G. P., & Barb, A. W. (2015) · Structure · doi:10.1016/j.str.2015.06.015 · Cited by 216
“…(DeLano et al., 2000) Fc + Z domain 2DTS 0.217 0.217 (Matsumiya et al., 2007) afucosylated 4KU1 0.252 0.260 (Frank et al., 2014) G2F 4BYH 0.270 0.226 (Crispin et al., 2013) disialyl 2WAH 0.306 0.295 (Crispin et al., 2009) M9N2 3AVE 0.306 0.218 (Matsumiya et al., 2007) fucosylated 3AY4 0.308 0.183…”
InfluentialMimura, Y., Katoh, T., Saldova, R., O’Flaherty, R., Izumi, T., Mimura-Kimura, Y., Utsunomiya, T., Mizukami, Y., Yamamoto, K., Matsumoto, T., et al. (2018) · Protein & Cell · doi:10.1007/s13238-017-0433-3 · Cited by 217
“4A, shown in red) projects away from the protein surface in a solvent-exposed manner, and the monosaccharides on the α(1-3)-arm are visible up to GlcNAc for the Fc chains (Crispin et al., 2013).”
BackgroundSeeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 179
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor
Subedi, G. P., & Barb, A. W. (2016) · mAbs · doi:10.1080/19420862.2016.1218586 · Cited by 174
“IgG1 Fc N-glycan do not interact with the Fc polypeptide directly.(30,43)”
BackgroundThe Ligands for Human IgG and Their Effector Functions
de Taeye, S. W., Rispens, T., & Vidarsson, G. (2019) · Antibodies · doi:10.3390/antib8020030 · Cited by 170
Human IgG4: a structural perspective
Davies, A. M., & Sutton, B. J. (2015) · Immunological Reviews · doi:10.1111/imr.12349 · Cited by 170
“Crystal structures for sialylated IgG1-Fc, in which the sialic acid residues are solvent exposed, differ in the position adopted by the Cc2 domains relative to the Cc3 domains (66, 67), but as yet there is no crystal structure available for a DC-SIGN/IgG-Fc complex.”
BackgroundAntigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Mahan, A. E., Jennewein, M. F., Suscovich, T. J., Dionne, K., Tedesco, J., Chung, A. W., Streeck, H., Pau, M. G., Schuitemaker, H., Francis, D., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005456 · Cited by 168
“inflammatory activity through binding to lectin-like receptors [19], though there is some controversy in the field as to whether IVIG’s anti-inflammatory effect is due to sialylation alone [20–22].”
BackgroundStructural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins
Ahmed, A. A., Giddens, J., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L.-X., & Bjorkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 154
“In our crystal structure of fully disialylated Fc, we found both open and closed CH2 domain conformations in the same crystal, and a previously published sFc structure [30] revealed a conformation similar to the canonical wtFc structures, again suggesting a large degree of inter-domain flexibility of sialylated forms…”
InfluentialTherapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
Cymer, F., Beck, H., Rohde, A., & Reusch, D. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.11.001 · Cited by 160
Campbell, I. K., Miescher, S., Branch, D. R., Mott, P. J., Lazarus, A. H., Han, D., Maraskovsky, E., Zuercher, A. W., Neschadim, A., Leontyev, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301611 · Cited by 136
“(48) followed by a rebuttal from Sondermann et al.”
MethodIgE Antibodies: From Structure to Function and Clinical Translation
Sutton, B. J., Davies, A. M., Bax, H. J., & Karagiannis, S. N. (2019) · Antibodies · doi:10.3390/antib8010019 · Cited by 152
“One glycosylation site is conserved across all antibody classes: Asn394 in the Cε3 domain of IgE, structurally homologous to Asn297 in the Cγ2 domain of IgG.”
BackgroundInfluentialMacro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies
Beck, A., & Liu, H. (2019) · Antibodies · doi:10.3390/antib8010018 · Cited by 138
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
Dekkers, G., Rispens, T., & Vidarsson, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00553 · Cited by 125
Glycobiology of rheumatic diseases
Kissel, T., Toes, R. E. M., Huizinga, T. W. J., & Wuhrer, M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00867-4 · Cited by 119
Structural analysis of glycoproteins: building N-linked glycans with Coot
Emsley, P., & Crispin, M. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318005119 · Cited by 116
“…2010); (ii) deliberate manipulation of the glycosyation pathway either during expression (see, for example, Crispin et al. (2009) or by in vitro enzymatic manipulation (see, for example, Krapp et al., 2003; Crispin et al., 2013); or (iii) analytical characterization of the glycans or glycopeptides.”
BackgroundSelf-citationNimmerjahn, F., Vidarsson, G., & Cragg, M. S. (2023) · Nature Immunology · doi:10.1038/s41590-023-01544-8 · Cited by 112
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 107
“This may mediate anti-inflammatory effects (285) and improve serum half-life (252), although contradicting studies report no effects of sialic acid on Fc conformation and recognition (286, 287).”
BackgroundAnalytical comparability study of recombinant monoclonal antibody therapeutics
Ambrogelly, A., Gozo, S., Katiyar, A., Dellatore, S. M., Kune, Y., Bhat, R., Sun, J., Li, N., Wang, D., Nowak, C., et al. (2018) · mAbs · doi:10.1080/19420862.2018.1438797 · Cited by 106
Fc gamma receptors: glycobiology and therapeutic prospects
Hayes, J. M., Wormald, M. R., Rudd, P. M., & Davey, G. P. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s121233 · Cited by 103
“A high sialic acid content has been proposed to impact the IgG Fc structure and force it to acquire a closed conformation resulting in decreased binding to FcγRs; however, X-ray crystallographic data suggest that this is not the case, and no major Fc structural alterations were observed with increased sialylation.(21,…”
The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals
Krištić, J., & Lauc, G. (2024) · Immunological Reviews · doi:10.1111/imr.13407 · Cited by 103
“42”
Structural analysis of Fc/FcγR complexes: a blueprint for antibody design
Caaveiro, J. M. M., Kiyoshi, M., & Tsumoto, K. (2015) · Immunological Reviews · doi:10.1111/imr.12365 · Cited by 103
Highly parallel characterization of IgG Fc binding interactions
Boesch, A. W., Brown, E. P., Cheng, H. D., Ofori, M. O., Normandin, E., Nigrovic, P. A., Alter, G., & Ackerman, M. E. (2014) · mAbs · doi:10.4161/mabs.28808 · Cited by 89
Immunoglobulin G1 Fc Domain Motions: Implications for Fc Engineering
Frank, M., Walker, R. C., Lanzilotta, W. N., Prestegard, J. H., & Barb, A. W. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.01.011 · Cited by 77
“[28,30–35]), in this study, we focused on those reported for human IgG1 Fc having Gal-terminated N-glycans and human IgG1 Fc in”
Subedi, G. P., Hanson, Q. M., & Barb, A. W. (2014) · Structure · doi:10.1016/j.str.2014.08.002 · Cited by 81
“, 2013)) though recent evidence suggests sialylation does not alter either Nglycan motion or the interface character to a large extent (Barb et al., 2012; Crispin et al., 2013).”
BackgroundCrystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
Li, W., Zhu, Z., Chen, W., Feng, Y., & Dimitrov, D. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01554 · Cited by 78
Avanzato, V. A., Oguntuyo, K. Y., Escalera‐Zamudio, M., Gutiérrez, B., Golden, M., Pond, S. L. K., Pryce, R., Walter, T. S., Seow, J., Doores, K. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912503116 · Cited by 73
Self-citationLiu, X., Cao, W., & Li, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01660 · Cited by 79
Strategies for carbohydrate model building, refinement and validation
Agirre, J. (2017) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316016910 · Cited by 64
“A recent example of such a situation is the structure of a sialylated IgG Fc fragment reported by Crispin et al. (2013), with PDB accession code 4byh.”
BackgroundProcessing of complex N-glycans in IgG Fc-region is affected by core fucosylation
Castilho, A., Gruber, C., Thader, A., Oostenbrink, C., Pechlaner, M., Steinkellner, H., & Altmann, F. (2015) · mAbs · doi:10.1080/19420862.2015.1053683 · Cited by 61
A Perspective on the Structure and Receptor Binding Properties of Immunoglobulin G Fc
Hanson, Q., & Barb, A. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00299 · Cited by 68
Yamaguchi, Y., & Barb, A. W. (2019) · Glycobiology · doi:10.1093/glycob/cwz068 · Cited by 62
“Several crystal structures of sialylated Fc have been reported from several groups (Crispin et al. 2013; Ahmed et al. 2014; Chen et al. 2017).”
BackgroundHuman DC-SIGN and CD23 do not interact with human IgG
Temming, A. R., Dekkers, G., van de Bovenkamp, F. S., Plomp, H. R., Bentlage, A. E. H., Szittner, Z., Derksen, N. I. L., Wuhrer, M., Rispens, T., & Vidarsson, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-46484-2 · Cited by 59
Fang, J. S., Richardson, J., Du, Z., & Zhang, Z. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01323 · Cited by 55
Kaufman, G., Massoud, A. H., Dembele, M., Yona, M., Piccirillo, C. A., & Mazer, B. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00469 · Cited by 59
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
Le, N. P. L., Bowden, T. A., Struwe, W. B., & Crispin, M. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.016 · Cited by 49
“sialic acid was projecting away from the protein-bound galactose residue in an entirely solvent accessible manner [45,55] (Fig.”
BackgroundSelf-citationImpact of Fc N-glycan sialylation on IgG structure
Zhang, Z., Shah, B., & Richardson, J. (2019) · mAbs · doi:10.1080/19420862.2019.1655377 · Cited by 46
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
Beyze, A., Larroque, C., & Quintrec, M. L. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00850-0 · Cited by 45
“This decreased affinity could potentially be caused by a conformational change of the Fc fragment from an open to a closed conformation 150,152,153 , thus inhibiting interaction with the Fc part.”
Tjon, A. S. W., van Gent, R., Geijtenbeek, T. B. H., & Kwekkeboom, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00197 · Cited by 47
Roghanian, A., Stopforth, R. J., Dahal, L. N., & Cragg, M. S. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0917-354r · Cited by 46
Garner, O. B., Yun, T., Pernet, O., Aguilar, H. C., Park, A., Bowden, T. A., Freiberg, A. N., Lee, B., & Baum, L. G. (2015) · Journal of Virology · doi:10.1128/jvi.02435-14 · Cited by 43
Self-citationSharma, M., Schoindre, Y., Hegde, P., Saha, C., Maddur, M. S., Victor, E. S., Gilardin, L., Lecerf, M., Bruneval, P., Mouthon, L., et al. (2014) · Scientific Reports · doi:10.1038/srep05672 · Cited by 43
Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
Czajkowsky, D. M., Andersen, J. T., Fuchs, A., Wilson, T. J., Mekhaiel, D., Colonna, M., He, J., Shao, Z., Mitchell, D. A., Wu, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09526 · Cited by 38
Parsy, M.-L., Harlos, K., Huiskonen, J. T., & Bowden, T. A. (2013) · Journal of Virology · doi:10.1128/jvi.02298-13 · Cited by 37
Self-citationChen, C.-L., Hsu, J.-C., Lin, C., Wang, C.-H., Tsai, M.-H., Wu, C., Wong, C., & Ma, C. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00140 · Cited by 42
Silva-Martín, N., Bartual, S. G., Ramírez-Aportela, E., Chacón, P., Park, C. G., & Hermoso, J. A. (2014) · Structure · doi:10.1016/j.str.2014.09.001 · Cited by 35
“…responsible for the interaction with the receptor (Sondermann et al., 2013a) and that the high-salt crystal structure of the a-2,6 sialylated antibody reported previously (Crispin et al., 2013) would not be representative of the conformational changes found in solution (Sondermann et al., 2013b).”
BackgroundEnhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines
Mimura, Y., Kelly, R. M., Unwin, L., Albrecht, S., Jefferis, R., Goodall, M., Mizukami, Y., Mimura-Kimura, Y., Matsumoto, T., Ueoka, H., et al. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.11.009 · Cited by 35
“On the other hand, distinct crystal structures of sialylated Fc (PDB IDs: 4BYH, 4Q6Y) suggest heterogeneity of the conformation of the sialylated CH2 domains (Crispin et al., 2013; Ahmed et al., 2014), which might be related to DC-SIGN engagement.”
BackgroundStructural Plasticity of the Semliki Forest Virus Glycome upon Interspecies Transmission
Crispin, M., Harvey, D. J., Bitto, D., Bonomelli, C., Edgeworth, M. J., Scrivens, J. H., Huiskonen, J. T., & Bowden, T. A. (2014) · Journal of Proteome Research · doi:10.1021/pr401162k · Cited by 36
Self-citationSweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G
Böhm, S., Kao, D., & Nimmerjahn, F. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_18 · Cited by 32
Liu, H., Nowak, C., Andrien, B. A., Shao, M., Ponniah, G., & Neill, A. (2017) · Biotechnology Progress · doi:10.1002/btpr.2498 · Cited by 35
“The sialic acids on the 1,6 and 1,3 arms are both solvent exposed.(44) Conformational changes caused by sialic acid are”
BackgroundImmunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies
Hematianlarki, M., & Nimmerjahn, F. (2024) · Immunological Reviews · doi:10.1111/imr.13404 · Cited by 32
Modeling of Oligosaccharides within Glycoproteins from Free-Energy Landscapes
Turupcu, A., & Oostenbrink, C. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00351 · Cited by 31
Cheng, H. D., Stöckmann, H., Adamczyk, B., McManus, C. A., Ercan, A., Holm, I. A., Rudd, P. M., Ackerman, M. E., & Nigrovic, P. A. (2017) · Glycobiology · doi:10.1093/glycob/cwx082 · Cited by 30
“2016), mechanism(s) associated with this role remain controversial (Crispin et al. 2013; Campbell et al. 2014).”
BackgroundGlycoblocks: a schematic three-dimensional representation for glycans and their interactions
McNicholas, S. J., & Agirre, J. (2016) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316013553 · Cited by 27
“A second example using antibodies (PDB code 4byh; Crispin et al., 2013) can be found in the supplementary video protocol.”
MethodSweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation
Brückner, C., Lehmann, C. H. K., Dudziak, D., & Nimmerjahn, F. (2017) · International Immunology · doi:10.1093/intimm/dxx053 · Cited by 30
Kamiya, Y., Satoh, T., & Kato, K. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.03.008 · Cited by 25
“For example, a2,6-sialylated IgG, which is endowed with anti-inflammatory activity, was prepared by a two-step reaction with b1,4-galactosyltransferase and a-2,6-sialyltransferase in vitro [34–36] and successfully subjected to crystal structure determination [37].”
MethodSpäth, P., Schneider, C., & von Gunten, S. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0422-x · Cited by 30
“…on mice experiments and results are controversially discussed due to conflicting findings from other groups (Bazin et al. 2006; Campbell et al. 2014; Crispin et al. 2013; Guhr et al. 2011; Käsermann et al. 2012; Leontyev et al. 2012a, b; Othy et al. 2014; von Gunten et al. 2014; Yu et al. 2013).”
Hatfield, G., Tepliakova, L., Gingras, G., Stalker, A., Li, X., Aubin, Y., & Tam, R. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.972168 · Cited by 23
Finke, J. M., & Banks, W. A. (2016) · Human Antibodies · doi:10.3233/hab-160306 · Cited by 24
“While a novel anti-inflammatory role for Fc sialylation has been proposed [7,79,136], this hypothesis has not been supported in studies of its molecular mechanism [42,139,159] and functional outcomes in select disease models [25,32,64,81,91,108,111,152].”
Analysis and validation of overall N -glycan conformation in Privateer
Dialpuri, J. S., Bagdonas, H., Atanasova, M., Schofield, L. C., Hekkelman, M. L., Joosten, R. P., & Agirre, J. (2023) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798323003510 · Cited by 23
Issekutz, A. C., Rowter, D., Miescher, S., & Käsermann, F. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.003 · Cited by 22
The therapeutic potential of sialylated Fc domains of human IgG
Pleass, R. J. (2021) · mAbs · doi:10.1080/19420862.2021.1953220 · Cited by 25
“Approaches to enhance the sialylation of IgG have to date focussed on modifications to the known preexisting N-linked glycosylation sites.(19,40,48,49) My colleagues and I took an alternative approach to enhancing the sialic acid content of the Fc of IgG1 by adding the 18 amino acid tailpiece from IgM that contains an…”
BackgroundStructure and Dynamics of Immunoglobulin G Glycoproteins
Yagi, H., Yanaka, S., & Kato, K. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-2158-0_11 · Cited by 25
Influence of glycan modification on IgG1 biochemical and biophysical properties
Pawlowski, J. W., Bajardi-Taccioli, A., Houde, D. J., Feschenko, M. S., Carlage, T., & Kaltashov, I. A. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.12.061 · Cited by 24
Solution structure of deglycosylated human IgG1 shows the role of CH2 glycans in its conformation
Spiteri, V. A., Doutch, J., Rambo, R. P., Gor, J., Dalby, P. A., & Perkins, S. J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.038 · Cited by 19
“Crystal structures for glycosylated human Fc regions revealed the two glycans to be found at the centre of the Fc region in contact with each other (PDB IDs: 4W4N, 4KU1, 4BM7, 3AVE, 4Q74, 4BYH, 1H3X) (21-27).”
BackgroundKavur, M. M., Lauc, G., & Pezer, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00086-9 · Cited by 19
Zlatina, K., & Galuska, S. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753294 · Cited by 19
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Purcell, R. A., Theisen, R. M., Arnold, K. B., Chung, A. W., & Selva, K. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183727 · Cited by 18
Avanzato, V. A., Bushmaker, T., Oguntuyo, K. Y., Yinda, C. K., Duyvesteyn, H. M. E., Stass, R., Meade-White, K. D., Rosenke, R., Thomas, T., van Doremalen, N., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00638-24 · Cited by 15
“(C ) The complex glycan (shown as light orange sticks) from the structure PDB 4BYH (48) was modeled onto the F2 glycan site on two protomers of NiV-F by alignment onto the first GlcNAc that was observed in the cryo-EM-derived reconstruction.”
Self-citationTargeting B cells and autoantibodies in the therapy of autoimmune diseases
Kao, D., Lux, A., Schwab, I., & Nimmerjahn, F. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0427-7 · Cited by 15
Sweet Rules: Linking Glycosylation to Antibody Function
Nimmerjahn, F., & Werner, A. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_12 · Cited by 15
Calow, J., Behrens, A., Mader, S., Bockau, U., Struwe, W. B., Harvey, D. J., Cormann, K. U., Nowaczyk, M. M., Loser, K., Schinor, D., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1228504 · Cited by 13
Self-citationBlundell, P. A., Lu, D., Wilkinson, M., Dell, A., Haslam, S., & Pleass, R. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801337 · Cited by 11
“A minority of these complex structures are also monosialylated (2, 23, 24).”
BackgroundImportance and Monitoring of Therapeutic Immunoglobulin G Glycosylation
Mimura, Y., Saldova, R., Mimura‐Kimura, Y., Rudd, P. M., & Jefferis, R. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_15 · Cited by 14
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation
Bauer-Smith, H., Sudol, A. S. L., Beers, S. A., & Crispin, M. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130448 · Cited by 10
“Moreover, there seems to be a lack of biophysical evidence that the Fc domain interacts with DC-SIGN regardless of sialylation status [305 – 307].”
Self-citationYageta, S., Imamura, H., Shibuya, R., & Honda, S. (2018) · mAbs · doi:10.1080/19420862.2018.1546086 · Cited by 8
Hatfield, G., Tepliakova, L., Tran, J. P., Lu, H., Gilbert, M., & Tam, R. Y. (2023) · mAbs · doi:10.1080/19420862.2023.2239405 · Cited by 7
Insights into substrate recognition and specificity for IgG by Endoglycosidase S2
Aytenfisu, A. H., Deredge, D. J., Klontz, E. H., Du, J. J., Sundberg, E. J., & MacKerell, A. D. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009103 · Cited by 7
“We also used the following names for the two arms or antennae of the glycan as 3-Arm and 6-Arm for the glycan arms with 1➔3 linkage and 1➔6 linkage respectively, as shown on Fig 13.[45] Once initial coordinates were generated for each system, they were immersed into a preequilibrated water box.”
MethodSondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311721110 · Cited by 7
Glycan Remodeling with Processing Inhibitors and Lectin-Resistant Eukaryotic Cells
Chang, V. T.-C., Spooner, R. A., Crispin, M., & Davis, S. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2760-9_21 · Cited by 4
Self-citationZhou, Y., Weiss, S. S., Tan, C., Bittner, P., Harrison, J. A., Tjernberg, L. O., Emmer, Å., & Zenobi, R. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03703 · Cited by 2
Mechanism of Action of Immunoglobulin: Sialylated IgG
Takai, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-56039-5_25
Production d'IgG sialylées en CHO et impact sur leurs fonctions effectrices
Raymond, C. (2015) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/26518 · Cited by 2
Mohaisn, I. K., AL-Mashhadani, Z. I., & Ali, B. (2014) · Ibn AL- Haitham Journal For Pure and Applied Science
Current IgG Products and Future Perspectives
Späth, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-68038-5_13
Pawlowski, J. W. (2018) · ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · doi:10.7275/11400795.0
Helali, Y. (2024) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
Cellular and molecular cross talk between basophils and CD4+ T cells
Sharma, M. (2014) · theses.fr (ABES) · doi:10.70675/59eb467fz88b2z471ez9163z5b8c7445747a
Deciphering the immune response to respiratory pathogens - Role of programmed death-ligand 1
Victor, E. S. (2016) · theses.fr (ABES) · doi:10.70675/42f25aeez159bz4bf3z8f30z05634e3e8152
Metadata
- Authors
- Crispin, M., Yu, X., & Bowden, T. A.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-08-08
- Volume
- 110
- Issue
- 38
- Pages
- E3544-6
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3780870
- OpenAlex
- W2032419556
- Cited by
- 89
- References
- 5
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 1 · 2019: 9 · 2018: 8 · 2017: 11 · 2016: 13 · 2015: 11 · 2014: 14 · 2013: 2
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust (090532)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- intravenous immunoglobulin, Fc glycosylation, sialic acid, antibody structure, Fc receptor binding
- MeSH terms
- Animals, Humans, Immunoglobulin Fc Fragments, Receptors, Cell Surface, Cell Adhesion Molecules, Receptors, IgG, Receptors, IgE, Lectins, C-Type
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.